• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Atrial Septal Defect and Pulmonary Arterial Hypertension

April 26, 2019 By Dr. Jeremy Feldman

atrial septal defect - pulmonary arterial hypertension

An Atrial Septal Defect (ASD) is a hole in the heart between the right and left top chambers (atria). This is not terribly uncommon with an estimated 1-2 per 1000 live births.  Most of these holes are small and do not cause long-term problems.  In some patients the hole is larger and can lead to extra blood flowing from the left side of the heart into … [Read more...]

Flu Vaccine in Young Adults with Congenital Heart Disease and Pulmonary Hypertension

October 14, 2016 By Dr. Jeremy Feldman

PH Support Group

By Tabitha Moe and Jeremy Feldman As a young adult with congenital heart disease, it is important for you to take responsibility for your own health and well being.  Over the years your parents and caregivers may have made decisions for you.  As a young adult, you now are in a position to make your own decisions about your health and wellness. We are approaching flu season, … [Read more...]

Living with Complex Congenital Heart Disease

June 20, 2016 By Dr. Jeremy Feldman

Internal anatomy of the pulmonary arteries

By Tabitha Moe and Jeremy Feldman A normal heart has 4 chambers: 2 top chambers and 2 bottom chambers.  In some patients, only a single bottom chamber (ventricle) develops.  These patients with a single ventricle are the most complex form of congenital heart disease. The first surgery to repair this defect occurred in 1968 and was published by Dr. Fontan in 1971.  The … [Read more...]

FAQ’s: Oral Treatments, Care Centers & Hole in Heart

June 1, 2016 By Dr. Jeremy Feldman

congenital heart disease atrial septal defect

Your Questions Answered Is there an oral treatment that can replace continuously infused therapy (Flolan/Remodulin)? Flolan and Remodulin are also called Prostanoids.  This family of medicine has been the backbone of PAH therapy for our sickest PAH patients more than for 15 years.  In the past 2 years, the FDA approved 2 oral medicines that are in the same class (prostanoid … [Read more...]

Congenital Heart Disease and Sleep Apnea

May 12, 2016 By Dr. Jeremy Feldman

Fatigued pulmonary hypertension patient

Co-Authored By Tabitha Moe and Jeremy Feldman As of 2011, there are more adults than children with congenital heart disease.  Children with congenital heart disease who were born in the 1980’s and 1990’s were given exercise restrictions that were quite limiting.  This kept them from participating in competitive sports, recreational sports, or even playing in gym class at … [Read more...]

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

PAH patient story

Pulmonary Hypertension and COVID-19

By Dr. Jeremy Feldman

We are in the midst of the greatest health crisis since HIV (human immunodeficiency virus).  The last time the

Generic medications for PH

Sildenafil (Revatio): Getting the Most Out of Your Medication

By Dr. Jeremy Feldman

Sildenafil (Revatio) was approved in 2005 based on a 12-week study that showed improvements in six minute walk distance.

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives